Frazier Life Sciences Management’s Alkermes ALKS Stock Holding History

Frazier Life Sciences Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.7M	Hold	700,647	–	–	0.8%	24
2026 Q1	$24.8M	Hold	700,647	–	–	0.64%	27
2025 Q4	$19.6M	Hold	700,647	–	–	0.53%	31
2025 Q3	$21M	Sell	700,647 -300,000	-30%	-$8.46M	0.63%	29
2025 Q2	$28.6M	Buy	1,000,647 +399,518	+66%	+$11.9M	1.14%	20
2025 Q1	$19.8M	Hold	601,129	–	–	0.91%	23
2024 Q4	$17.3M	Buy	601,129 +25,000	+4%	+$719K	0.72%	29
2024 Q3	$16.1M	Buy	+576,129	New	+$15.4M	0.65%	33

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Frazier Life Sciences Management's ALKS Position: Q2 2026 in Review

Frazier Life Sciences Management held its Alkermes (ALKS) position steady in Q2 2026 at 700,647 shares worth $36.7M. The position accounts for 0.8% of the portfolio, ranked #24.

Frazier Life Sciences Management first reported a position in ALKS in Q3 2024 and has held it in 8 quarters since. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

Frazier Life Sciences Management held 700,647 shares of Alkermes worth $36.7M as of Q2 2026.
Frazier Life Sciences Management left its Alkermes share count unchanged in Q2 2026.
Alkermes made up 0.8% of Frazier Life Sciences Management's portfolio in Q2 2026, its #24 holding.
Frazier Life Sciences Management first reported a position in Alkermes in Q3 2024 and has held it in 8 quarters since.
425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Frazier Life Sciences Management's 13F filing for Q2 2026, filed 14 Aug 2026.